121 related articles for article (PubMed ID: 37403606)
21. A novel remote assessment pathway to streamline the management of two-week-wait suspected head and neck cancer referrals: a prospective analysis of 660 patients.
Metcalfe C; Oh S; Glazzard N; Ross E; George A
J Laryngol Otol; 2024 Jun; 138(6):667-671. PubMed ID: 38369910
[TBL] [Abstract][Full Text] [Related]
22. Patient Satisfaction With the Head and Neck Cancer Telephone Triage Service During the COVID-19 Pandemic.
Zhu Y; Chen Z; Ding A; Walter H; Easto R; Wilde A
Cureus; 2021 Sep; 13(9):e18375. PubMed ID: 34729263
[TBL] [Abstract][Full Text] [Related]
23. Implementation of a telemedicine service to provide skin cancer care in a tertiary plastic surgery unit during COVID-19 - a comprehensive review.
Jakeman M; Khaw R; Zack-Williams S; Brackley P
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3608-3615. PubMed ID: 35739023
[TBL] [Abstract][Full Text] [Related]
24. Treatment prioritization and risk stratification of head and neck cancer during COVID-19 pandemic: A systematic review.
Adham M; Anam K; Reksodiputro L
Med J Malaysia; 2022 Jan; 77(1):53-59. PubMed ID: 35086995
[TBL] [Abstract][Full Text] [Related]
25. Rethinking the 'one-stop' neck lump clinic: a novel pathway beyond coronavirus disease 2019.
Hariri A; Jawad S; Otero S; Lechner M; Morley S; Beale T; Hughes J; Stimpson P; Dwivedi R; Vaz F
J Laryngol Otol; 2023 Jun; 137(6):704-708. PubMed ID: 36815299
[TBL] [Abstract][Full Text] [Related]
26. Impact of primary care triage using the Head and Neck Cancer Risk Calculator version 2 on tertiary head and neck services in the post-coronavirus disease 2019 period.
Tan JY; Callaghan CJ; Lewthwaite AW; Chan CCH; Wee CT; To EYH; Summers I; Nelson JW; Smith MB; Li LQ; Morton C; Porteous L; Evans AS; Nixon IJ
J Laryngol Otol; 2024 Jan; ():1-6. PubMed ID: 38250823
[TBL] [Abstract][Full Text] [Related]
27. Telephone clinic outcomes during the coronavirus disease 2019 pandemic: results from an ENT department.
Mallick S; Balakumar R; Drysdale A
J Laryngol Otol; 2022 Jul; 136(7):611-614. PubMed ID: 34526174
[TBL] [Abstract][Full Text] [Related]
28. The role of the Head and Neck cancer-specific Patient Concerns Inventory (PCI-HN) in telephone consultations during the COVID-19 pandemic.
Kanatas A; Rogers SN
Br J Oral Maxillofac Surg; 2020 Jun; 58(5):497-499. PubMed ID: 32340765
[No Abstract] [Full Text] [Related]
29. A Retrospective Audit of the Triage Process Introduced for Breast Referrals Received During the Covid-19 Pandemic.
Mackender E; Dave R; Tudor D; Harvey J
Clin Breast Cancer; 2024 Jun; 24(4):e219-e225. PubMed ID: 38368248
[TBL] [Abstract][Full Text] [Related]
30. Telephone versus face-to-face clinics for the management of new rhinology referrals: a retrospective cohort study.
Metcalfe C; Mughal Z; Beech T
J Laryngol Otol; 2023 Jul; 137(7):810-814. PubMed ID: 36636826
[TBL] [Abstract][Full Text] [Related]
31. Two week wait referral criteria - heading in the right direction?
Gao C; Qin C; Freeman S; Oskooee N; Hughes J
J Laryngol Otol; 2019 Aug; 133(8):704-712. PubMed ID: 31370911
[TBL] [Abstract][Full Text] [Related]
32. Impact of COVID-19 pandemic on head-neck cancer referral and treatment pathway in North East London.
Zubair A; Jamshaid S; Scholfield DW; Hariri AA; Ahmed J; Ghufoor K; Ali S
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S28-S34. PubMed ID: 35446702
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of urgent suspicion of head and neck cancer referrals in Glasgow.
Douglas CM; Carswell V; Montgomery J
Ann R Coll Surg Engl; 2019 Feb; 101(2):103-106. PubMed ID: 30372125
[TBL] [Abstract][Full Text] [Related]
34. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
Tikka T; Kavanagh K; Lowit A; Jiafeng P; Burns H; Nixon IJ; Paleri V; MacKenzie K
Clin Otolaryngol; 2020 May; 45(3):380-388. PubMed ID: 31985180
[TBL] [Abstract][Full Text] [Related]
35. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
[TBL] [Abstract][Full Text] [Related]
36. Deprivation in relation to urgent suspicion of head and neck cancer referrals in Glasgow.
Zeitler M; Fingland P; Tikka T; Douglas CM; Montgomery J
Clin Otolaryngol; 2018 Jun; 43(3):861-867. PubMed ID: 29380938
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 did not delay time from referral to definitive management for head and neck cancer patients in a regional Victorian centre.
Tan H; Preston J; Hunn S; Kwok M; Borschmann M
ANZ J Surg; 2021 Jul; 91(7-8):1364-1368. PubMed ID: 34185361
[TBL] [Abstract][Full Text] [Related]
38. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
39. Outcomes for patients referred urgently with suspected head and neck cancer.
Hobson JC; Malla JV; Sinha J; Kay NJ; Ramamurthy L
J Laryngol Otol; 2008 Nov; 122(11):1241-4. PubMed ID: 18371234
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of the Head and Neck Cancer Risk Calculator in identifying maxillofacial malignancies.
Simpson CD; Hennigan M; Morrison J
Br J Oral Maxillofac Surg; 2023 Jun; 61(5):356-361. PubMed ID: 37169617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
